Brexit costs and red tape denying NHS cancer patients life-saving drugs, report finds
Brexit costs and red tape are denying British cancer patients life-saving drugs and trials of revolutionary treatments, a damning new report has warned. Soaring numbers are being diagnosed with cancer as the population grows alongside improvements in diagnosis and public awareness, heightening the importance of global cooperation on new treatments. But, five years after Britain left the European Union, an in-depth analysis has concluded that Britons with cancer have “lost out” due to rising costs and post-Brexit red tape. By contrast, patients across Europe are enjoying a golden age of pioneering research and new treatments, it found. Brexit red tape is denying British cancer patients life-saving drugs More